Life sciences firm Danaher to launch AI-powered autonomous research lab in 2027

October 7, 2026 7:34 AM EDT

FILE PHOTO: Letters spelling "AI", a keyboard and a robotics hand in this illustration taken, September 23, 2026. REUTERS/Dado Ruvic/Illustration/File Photo

Oct 7 (Reuters) - Life ‌sciences company ​Danaher ​said on Wednesday it plans to launch its first AI-powered autonomous ‌research lab early next year to ⁠make drug discovery and development faster and more ‌efficient.

Here are more details:

• ‌The lab, projected to operate at scale in early 2027, will combine AI, robotics ​and technologies from several Danaher operating companies in one connected workflow to ⁠develop custom antibodies and other molecular tools

• It is expected ​to make discovering molecules eight times faster and unlock a tenfold increase ​in generating target-binding molecules ‌annually

• "That frees them (scientists) to focus on the complex scientific challenges where ⁠human insight matters most," said JC Gutierrez-Ramos, chief science officer of Danaher

• The lab uses ⁠AI to help create new molecules that can ​bind specifically to a biological target, including antibodies, then builds and tests each one, feeding every result ‌back into the model to improve the next design

• The lab ‌is an example of a broader ⁠program across Danaher, ‌intended to create ​a fleet of smart instruments, the company said

(Reporting by Sneha S K in ‌Bengaluru)



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Reuters